Raymond James & Associates’s Innovator US Equity Buffer ETF March BMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.21M Hold
26,789
﹤0.01% 2565
2024
Q2
$1.16M Sell
26,789
-610
-2% -$25.5K ﹤0.01% 2532
2024
Q1
$1.14M Buy
27,399
+899
+3% +$36.4K ﹤0.01% 2510
2023
Q4
$1.05M Sell
26,500
-1,700
-6% -$63.9K ﹤0.01% 2484
2023
Q3
$1.02M Sell
28,200
-97,213
-78% -$3.62M ﹤0.01% 2445
2023
Q2
$4.65M Buy
125,413
+39,270
+46% +$1.39M ﹤0.01% 1527
2023
Q1
$2.99M Buy
86,143
+56,443
+190% +$1.89M ﹤0.01% 1803
2022
Q4
$956K Sell
29,700
-2,000
-6% -$63.7K ﹤0.01% 2454
2022
Q3
$956K Sell
31,700
-4,800
-13% -$155K ﹤0.01% 2424
2022
Q2
$1.13M Sell
36,500
-4,000
-10% -$131K ﹤0.01% 2361
2022
Q1
$1.42M Buy
+40,500
New +$1.39M ﹤0.01% 2369

Other funds holding BMAR

Raymond James & Associates's BMAR Position: Q3 2024 in Review

Raymond James & Associates held its Innovator US Equity Buffer ETF March (BMAR) position steady in Q3 2024 at 26,789 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Raymond James & Associates first reported a position in BMAR in Q1 2022 and has held it in 11 quarters since. The position peaked at $4.65M in Q2 2023. 95 funds tracked by Wall St. Rank hold BMAR as of Q3 2024.

  • Raymond James & Associates held 26,789 shares of Innovator US Equity Buffer ETF March worth $1.21M as of Q3 2024.
  • Raymond James & Associates left its Innovator US Equity Buffer ETF March share count unchanged in Q3 2024.
  • Innovator US Equity Buffer ETF March made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2565 holding.
  • Raymond James & Associates first reported a position in Innovator US Equity Buffer ETF March in Q1 2022 and has held it in 11 quarters since.
  • Raymond James & Associates's Innovator US Equity Buffer ETF March position peaked at $4.65M in Q2 2023.
  • 95 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF March as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.